Plug Power (NASDAQ:PLUG)- Frontline Active Stocks in Broker Choice: ITUS Corporation (NASDAQ:ITUS)

Plug Power Inc. (NASDAQ:PLUG) [Trend Analysis] attempts to attain leading position in street, Shares price changes as it 38.82% to close at $1.18 with the total traded volume of 24.62 Million shares. Plug Power Inc. (PLUG) revealed that firm will host a business update conference call on February 24, 2017. On this call, CEO, Andy Marsh, will discuss preliminary results for the full year of 2016.Additionally, Marsh will discuss expansion and growth plans for 2017. This will include continued momentum within the material handling business as well as the promising electric vehicle market in China.

“The Plug Power team is making substantial contributions, every day, not just with leadership in fuel cell power for industrial electric vehicles, but also with hydrogen fueling station and service solutions, which are accelerating mass adoption,” said Andy Marsh. “I’m looking forward to providing an update on Plug Power’s important footprint in building this industry and the hydrogen economy, as the world embraces electric drive trains.” The firm has institutional ownership of 23.50%, while insider ownership included 0.70%. Its price to sales ratio ended at 1.77. PLUG attains analyst recommendation of 2.20 with week’s performance of 25.53%.

ITUS Corporation (NASDAQ:ITUS) [Trend Analysis] try to make new thrust in street and making different trends, stocks trading ended with 11.83% to $5.20. TUS Corporation (NASDAQ:ITUS) is changing the Record Date for its current stock rights offering. The new Record Date will be Wednesday, March 1, 2017. For new shareholders to be eligible for the rights offering, shareholders will need to purchase ITUS common stock by Friday, February 24, 2017.

Robert Berman, ITUS’ President and CEO stated, “We are changing the Record Date due to the recent surged level of interest in ITUS and because we are presenting at 3 major investor conferences over the next two weeks in the United States and Europe.”

Proceeds from the rights offering will be used for general working capital purposes, including the continued development of Cchek, and to further strengthen the company’s balance sheet by reducing the company’s debt. Because the rights are not transferable, the rights cannot be sold, borrowed, assigned, or traded, and the only way to obtain the rights is to be a shareholder of record as of February 24, 2017. The share price of ITUS attracts active investors, as stock price of week volatility recorded 5.81%. The stock is going forward to its 52-week low with 176.60% and lagging behind from its 52-week high price with -23.75%.


About Gerard Bergeron

Gerard Bergeron covers Bio-pharmacy or healthcare sector Press Releases news updates. He has extensive three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Reply

Your email address will not be published. Required fields are marked *